» Articles » PMID: 34807779

The Relationship Between Gene & Various Diseases and Prevention Strategies

Overview
Journal Drug Metab Rev
Publisher Informa Healthcare
Specialty Pharmacology
Date 2021 Nov 22
PMID 34807779
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

UDP-glucuronyltransferase 1A1 (UGT1A1) is a member of the Phase II metabolic enzyme family and the only enzyme that can metabolize detoxified bilirubin. Inactivation and very low activity of UGT1A1 in the liver can be fatal or lead to lifelong Gilbert's syndrome (GS) and Crigler-Najjar syndrome (CN). To date, more than one hundred UGT1A1 polymorphisms have been discovered. Although most UGT1A1 polymorphisms are not fatal, which diseases might be associated with low activity UGT1A1 or UGT1A1 polymorphisms? This scientific topic has been studied for more than a hundred years, there are still many uncertainties. Herein, this article will summarize all the possibilities of gene-related diseases, including GS and CN, neurological disease, hepatobiliary disease, metabolic difficulties, gallstone, cardiovascular disease, Crohn's disease (CD) obesity, diabetes, myelosuppression, leukemia, tumorigenesis, etc., and provide guidance for researchers to conduct in-depth study on gene-related diseases. In addition, this article not only summarizes the prevention strategies of gene-related diseases, but also puts forward some insights for sharing.

Citing Articles

Relationship between mucin gene polymorphisms and different types of gallbladder stones.

Ren G, Fan Y, Zhong R, Zou G, Huang X, Zhang Y BMC Med Genomics. 2025; 18(1):22.

PMID: 39885433 PMC: 11783967. DOI: 10.1186/s12920-025-02090-y.


Proteomic analysis of mouse liver lesions at all three stages of Echinococcus granulosus infection.

Jiang N, Chen Y, Li T, Sun Y, Su Y, Wang Y PLoS Negl Trop Dis. 2024; 18(12):e0012659.

PMID: 39625960 PMC: 11614251. DOI: 10.1371/journal.pntd.0012659.


Childhood obesity and risk of inflammatory bowel disease in adulthood: A Mendelian randomization study.

Luan Z, Wang J, Zhao Z, Chen Y, Zhang H, Wu J Medicine (Baltimore). 2024; 103(48):e40478.

PMID: 39612455 PMC: 11608687. DOI: 10.1097/MD.0000000000040478.


Targeting uridine diphosphate glucuronosyltransferase 1A1 in liver disease: Current research and future directions.

Park S, Kim Y, Kim J World J Gastroenterol. 2024; 30(39):4305-4307.

PMID: 39492821 PMC: 11525851. DOI: 10.3748/wjg.v30.i39.4305.


Drug-drug interactions of plant alkaloids derived from herbal medicines on the phase II UGT enzymes: an introductory review.

Gunasaykaran S, Chear N, Ismail S, Mohammad N, Murugaiyah V, Ramanathan S Naunyn Schmiedebergs Arch Pharmacol. 2024; 398(2):1447-1464.

PMID: 39325152 DOI: 10.1007/s00210-024-03418-8.